Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Dermal absorption

Currently viewing:

Administrative data

Endpoint:
dermal absorption in vivo
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Justification for type of information:
Refer to the Analogue Approach Justification document provided in IUCLID Section 13.
Cross-reference
Reason / purpose for cross-reference:
read-across source
Reference
Endpoint:
dermal absorption in vivo
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Expert judgement combined with experimental data.
Justification for type of information:
Refer to the Analogue Approach Justification document provided in IUCLID Section 13.
Principles of method if other than guideline:
No guideline exists for this type of appraisal.
GLP compliance:
no
Radiolabelling:
other: partly
Species:
other: human, rat, guinea-pig
Details on test animals or test system and environmental conditions:
not applicable
Type of coverage:
other: Various, for details see HERA report and SIDS
Vehicle:
not specified
Duration of exposure:
Various, for details see HERA report and SIDS
Doses:
Various, for details see HERA report and SIDS
No. of animals per group:
Various, for details see HERA report and SIDS
Absorption in different matrices:
Absorption by the percutaneous route is limited, since anionic surfactants tend to bind to the skin surface (Howes, 1975; Black and Howes, 1980). Early studies with isolated human skin were unable to detect penetration of a homologous series of AS, ranging from C8 to C18 (Blank and Gould, 1961). Animal studies confirmed a low level of percutaneous absorption of AS. Less than 0.4% of a 3 μmol dose of 35S-labeled C12AS-Na was percutaneously absorbed in guinea pigs, based on recovery of the radiolabel in urine, faeces and expired air (Prottey and Ferguson, 1975). Studies with rats indicated that pre-washing of the skin with surfactant enhanced AS skin penetration (Black and Howes, 1980).

For consumer exposure, actual dermal absorption is below 1% (Rice, 1977) or very low (Schäfer and Redelmeier, 1996), therefore a default assumption of 1% dermal absorption was taken for deriving the DNEL. Since the dermal absorption decreases with increasing concentration of a solution this percentage can be expanded to workers as a worst case approach.
Conversion factor human vs. animal skin:
not applicable

Data source

Materials and methods

Principles of method if other than guideline:
No guideline exists for this type of appraisal.

Test material

Constituent 1
Reference substance name:
Sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, zinc salts
Molecular formula:
Not applicable. UVCB substance
IUPAC Name:
Sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, zinc salts

Results and discussion

Absorption in different matrices:
Absorption by the percutaneous route is limited, since anionic surfactants tend to bind to the skin surface (Howes, 1975; Black and Howes, 1980). Early studies with isolated human skin were unable to detect penetration of a homologous series of AS, ranging from C8 to C18 (Blank and Gould, 1961). Animal studies confirmed a low level of percutaneous absorption of AS. Less than 0.4% of a 3 μmol dose of 35S-labeled C12AS-Na was percutaneously absorbed in guinea pigs, based on recovery of the radiolabel in urine, faeces and expired air (Prottey and Ferguson, 1975). Studies with rats indicated that pre-washing of the skin with surfactant enhanced AS skin penetration (Black and Howes, 1980).

For consumer exposure, actual dermal absorption is below 1% (Rice, 1977) or very low (Schäfer and Redelmeier, 1996), therefore a default assumption of 1% dermal absorption was taken for deriving the DNEL. Since the dermal absorption decreases with increasing concentration of a solution this percentage can be expanded to workers as a worst case approach.
Conversion factor human vs. animal skin:
not applicable

Applicant's summary and conclusion